Data / Drug companies / Mycophenolic acid
Mycophenolic acid: 16 companies and 35 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Mycophenolic acid is listed in the FDA National Drug Code Directory by 16 companies, with 35 products in commercial distribution. 33 of the products (94.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, delayed release, and the newest product started marketing on September 11, 2026.
The request: Get every company that lists mycophenolic acid in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 35
- Generic (ANDA) products
- 33 (94.3%)
- Application numbers
- 10
- Routes
- Oral
- Brand names
- Myfortic
- openFDA record search
- api.fda.gov
Companies that list mycophenolic acid
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ascend Laboratories, LLC | 4 | tablet, delayed release | Generic drugs (ANDA) | April 21, 2026 |
| Biocon Pharma Inc. | 4 | tablet, delayed release | Generic drugs (ANDA) | September 30, 2024 |
| Major Pharmaceuticals | 3 | tablet, delayed release | Generic drugs (ANDA) | April 15, 2025 |
| Accord Healthcare Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | September 11, 2017 |
| Advagen Pharma Ltd | 2 | tablet, delayed release | Generic drugs (ANDA) | November 10, 2023 |
| American Health Packaging | 2 | tablet, delayed release | Generic drugs (ANDA) | April 2, 2015 |
| Apotex Corp. | 2 | tablet, delayed release | Generic drugs (ANDA) | August 19, 2014 |
| Aurobindo Pharma Limited | 2 | tablet, delayed release | Generic drugs (ANDA) | February 27, 2024 |
| Concord Biotech Limited | 2 | tablet, delayed release | Generic drugs (ANDA) | December 13, 2019 |
| Golden State Medical Supply, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | August 19, 2014 |
| Novartis Pharmaceuticals Corporation | 2 | tablet, delayed release | New drug applications (NDA) | February 27, 2004 |
| Novugen Pharma (USA) LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | September 1, 2024 |
| Slate Run Pharmaceuticals, LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | May 19, 2021 |
| Stellon Biotech Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | September 11, 2026 |
| A-S Medication Solutions | 1 | tablet, delayed release | Generic drugs (ANDA) | September 24, 2021 |
| Remedyrepack Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | July 15, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, delayed release | 35 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 33 | 94.3% |
| New drug applications (NDA) | 2 | 5.7% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antimetabolite Immunosuppressant | 35 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.